168 related articles for article (PubMed ID: 33199827)
21. Involvement of Ataxin-3 (ATXN3) in the malignant progression of pancreatic cancer via deubiquitinating HDAC6.
Wu X; Zhang X; Liu P; Wang Y
Pancreatology; 2023 Sep; 23(6):630-641. PubMed ID: 37460341
[TBL] [Abstract][Full Text] [Related]
22. Characterization of GRK5 as a novel regulator of rhabdomyosarcoma tumor cell growth and self-renewal.
Pham T; Robinson K; Vleeshouwer-Neumann T; Annis JE; Chen EY
Oncotarget; 2020 Apr; 11(16):1448-1461. PubMed ID: 32363002
[TBL] [Abstract][Full Text] [Related]
23. HDAC6 and SIRT2 promote bladder cancer cell migration and invasion by targeting cortactin.
Zuo Q; Wu W; Li X; Zhao L; Chen W
Oncol Rep; 2012 Mar; 27(3):819-24. PubMed ID: 22089141
[TBL] [Abstract][Full Text] [Related]
24. The CXCR4-SDF1alpha axis is a critical mediator of rhabdomyosarcoma metastatic signaling induced by bone marrow stroma.
Strahm B; Durbin AD; Sexsmith E; Malkin D
Clin Exp Metastasis; 2008; 25(1):1-10. PubMed ID: 17768666
[TBL] [Abstract][Full Text] [Related]
25. HDAC6 suppresses microRNA-199a transcription and augments HPV-positive cervical cancer progression through Wnt5a upregulation.
Shao Y; Zhu F; Zhu S; Bai L
Int J Biochem Cell Biol; 2021 Jul; 136():106000. PubMed ID: 33933678
[TBL] [Abstract][Full Text] [Related]
26. Hedgehog signal inhibitors suppress the invasion of human rhabdomyosarcoma cells.
Oue T; Uehara S; Yamanaka H; Nomura M; Usui N
Pediatr Surg Int; 2013 Nov; 29(11):1153-8. PubMed ID: 23989521
[TBL] [Abstract][Full Text] [Related]
27. Suppression of miR-22, a tumor suppressor in cervical cancer, by human papillomavirus 16 E6 via a p53/miR-22/HDAC6 pathway.
Wongjampa W; Ekalaksananan T; Chopjitt P; Chuerduangphui J; Kleebkaow P; Patarapadungkit N; Pientong C
PLoS One; 2018; 13(10):e0206644. PubMed ID: 30379969
[TBL] [Abstract][Full Text] [Related]
28. Histone deacetylase 6 and cytoplasmic linker protein 170 function together to regulate the motility of pancreatic cancer cells.
Li D; Sun X; Zhang L; Yan B; Xie S; Liu R; Liu M; Zhou J
Protein Cell; 2014 Mar; 5(3):214-23. PubMed ID: 24474193
[TBL] [Abstract][Full Text] [Related]
29. miR-203, a tumor suppressor frequently down-regulated by promoter hypermethylation in rhabdomyosarcoma.
Diao Y; Guo X; Jiang L; Wang G; Zhang C; Wan J; Jin Y; Wu Z
J Biol Chem; 2014 Jan; 289(1):529-39. PubMed ID: 24247238
[TBL] [Abstract][Full Text] [Related]
30. Analysis of Expression and Functions of Histone Deacetylase 6 (HDAC6).
Li M; Zhuang Y; Shan B
Methods Mol Biol; 2016; 1436():85-94. PubMed ID: 27246209
[TBL] [Abstract][Full Text] [Related]
31. LEF1 reduces tumor progression and induces myodifferentiation in a subset of rhabdomyosarcoma.
Dräger J; Simon-Keller K; Pukrop T; Klemm F; Wilting J; Sticht C; Dittmann K; Schulz M; Leuschner I; Marx A; Hahn H
Oncotarget; 2017 Jan; 8(2):3259-3273. PubMed ID: 27965462
[TBL] [Abstract][Full Text] [Related]
32. Signaling pathways in Rhabdomyosarcoma invasion and metastasis.
Ramadan F; Fahs A; Ghayad SE; Saab R
Cancer Metastasis Rev; 2020 Mar; 39(1):287-301. PubMed ID: 31989508
[TBL] [Abstract][Full Text] [Related]
33. Vitamin K
Dawood M; Hegazy MF; Elbadawi M; Fleischer E; Klinger A; Bringmann G; Kuntner C; Shan L; Efferth T
Biochem Pharmacol; 2020 Oct; 180():114176. PubMed ID: 32721508
[TBL] [Abstract][Full Text] [Related]
34. Vangl2/RhoA Signaling Pathway Regulates Stem Cell Self-Renewal Programs and Growth in Rhabdomyosarcoma.
Hayes MN; McCarthy K; Jin A; Oliveira ML; Iyer S; Garcia SP; Sindiri S; Gryder B; Motala Z; Nielsen GP; Borg JP; van de Rijn M; Malkin D; Khan J; Ignatius MS; Langenau DM
Cell Stem Cell; 2018 Mar; 22(3):414-427.e6. PubMed ID: 29499154
[TBL] [Abstract][Full Text] [Related]
35. Pin1 coordinates HDAC6 upregulation with cell migration in lung cancer cells.
Chuang HH; Hsu JF; Chang HL; Wang PH; Wei PJ; Wu DW; Huang MS; Hsiao M; Yang CJ
Int J Med Sci; 2020; 17(17):2635-2643. PubMed ID: 33162791
[TBL] [Abstract][Full Text] [Related]
36. Alternative splicing of MEF2C pre-mRNA controls its activity in normal myogenesis and promotes tumorigenicity in rhabdomyosarcoma cells.
Zhang M; Zhu B; Davie J
J Biol Chem; 2015 Jan; 290(1):310-24. PubMed ID: 25404735
[TBL] [Abstract][Full Text] [Related]
37.
Pérez-Salvia M; Aldaba E; Vara Y; Fabre M; Ferrer C; Masdeu C; Zubia A; Sebastian ES; Otaegui D; Llinàs-Arias P; Rosselló-Tortella M; Berdasco M; Moutinho C; Setien F; Villanueva A; González-Barca E; Muncunill J; Navarro JT; Piris MA; Cossio FP; Esteller M
Haematologica; 2018 Nov; 103(11):e537-e540. PubMed ID: 29880608
[No Abstract] [Full Text] [Related]
38. Posttranslational modification and beyond: interplay between histone deacetylase 6 and heat-shock protein 90.
Liu P; Xiao J; Wang Y; Song X; Huang L; Ren Z; Kitazato K; Wang Y
Mol Med; 2021 Sep; 27(1):110. PubMed ID: 34530730
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors.
Chadalapaka G; Jutooru I; Sreevalsan S; Pathi S; Kim K; Chen C; Crose L; Linardic C; Safe S
Int J Cancer; 2013 Feb; 132(4):795-806. PubMed ID: 22815231
[TBL] [Abstract][Full Text] [Related]
40. Constitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression.
Skrzypek K; Kusienicka A; Szewczyk B; Adamus T; Lukasiewicz E; Miekus K; Majka M
Oncotarget; 2015 Oct; 6(31):31378-98. PubMed ID: 26384300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
